The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
BLLN · Healthcare · Narrow moat
On the watchlist
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
| Measure | BLLN | TCMD | ENSG | GILD |
|---|---|---|---|---|
| Moat Score (0–100) | 72 | 73 (highest) | 72 | 71 |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 85 | 75 | 95 (highest) | 70 |
| Pricing power | 59 | 100 (highest) | 33 | 99 |
| Returns on capital | — | 27 | 74 | 100 (highest) |
| Balance-sheet safety | 100 (highest) | 100 (highest) | 100 (highest) | 47 |
| Capital allocation | 44 | 60 (highest) | 60 (highest) | 39 |
| No price data | 110% above value if growth stopped today (largest discount to value if growth stopped today) | 305% above value if growth stopped today | 118% above value if growth stopped today | |
| Market cap | $2.2B | $498M | $10.1B | $186.3B |
| Moat tier | Narrow moat | Narrow moat | Narrow moat | Narrow moat |
| Filing date | FY2025 | FY2025 | FY2025 | FY2025 |